204 related articles for article (PubMed ID: 32029248)
21. TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket Study.
Tchétché D; Chevalier B; Holzhey D; Harnath A; Schäfer U; Teiger E; Manigold T; Modine T; Souteyrand G; Champagnac D; Oh JK; Li S; Verhoye JP; Kornowski R;
JACC Cardiovasc Interv; 2019 May; 12(10):923-932. PubMed ID: 31122349
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
Witberg G; Lador A; Yahav D; Kornowski R
Catheter Cardiovasc Interv; 2018 Aug; 92(2):408-416. PubMed ID: 29388308
[TBL] [Abstract][Full Text] [Related]
23. Outcome of Patients with Low-Gradient Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement.
Kugelman N; Jaffe R; Aronson D; Sharoni E; Adawi S; Khader N; Shiran A
Cardiovasc Revasc Med; 2020 Mar; 21(3):257-262. PubMed ID: 31103371
[TBL] [Abstract][Full Text] [Related]
24. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.
Tam DY; Hughes A; Fremes SE; Youn S; Hancock-Howard RL; Coyte PC; Wijeysundera HC
J Thorac Cardiovasc Surg; 2018 May; 155(5):1978-1988.e1. PubMed ID: 29454487
[TBL] [Abstract][Full Text] [Related]
25. TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial.
Waksman R; Corso PJ; Torguson R; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Buchbinder M; Asch F; Weissman G; Ben-Dor I; Shults C; Bastian R; Craig PE; Ali S; Garcia-Garcia HM; Kolm P; Zou Q; Satler LF; Rogers T
JACC Cardiovasc Interv; 2019 May; 12(10):901-907. PubMed ID: 30860059
[TBL] [Abstract][Full Text] [Related]
26. Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: A meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abubakar H; Subahi A; Chahine A; Ahmed S; Bachuwa G; Alkotob ML; Hassan M; Bhatt DL
Cardiovasc Revasc Med; 2019 Oct; 20(10):838-842. PubMed ID: 30638890
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
[TBL] [Abstract][Full Text] [Related]
28. When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018.
Wyler von Ballmoos MC; Barker CM; Reul RM; Dadu R; Ramchandani M; Kleiman NS; Reardon MJ
Cardiovasc Revasc Med; 2018 Mar; 19(2):139-141. PubMed ID: 29661491
[No Abstract] [Full Text] [Related]
29. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
[TBL] [Abstract][Full Text] [Related]
30. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
Pineda AM; Kevin Harrison J; Kleiman NS; Reardon MJ; Conte JV; O'Hair DP; Chetcuti SJ; Huang J; Yakubov SJ; Popma JJ; Beohar N
Catheter Cardiovasc Interv; 2019 Mar; 93(4):740-748. PubMed ID: 30341970
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.
Crestanello JA; Popma JJ; Adams DH; Deeb GM; Mumtaz M; George B; Huang J; Reardon MJ
JACC Cardiovasc Interv; 2017 Nov; 10(22):2283-2293. PubMed ID: 29102579
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement.
de Freitas Campos Guimarães L; Urena M; Wijeysundera HC; Munoz-Garcia A; Serra V; Benitez LM; Auffret V; Cheema AN; Amat-Santos IJ; Fisher Q; Himbert D; Garcia Del Blanco B; Dager A; Le Breton H; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
Circ Cardiovasc Interv; 2018 Sep; 11(9):e007038. PubMed ID: 30354588
[TBL] [Abstract][Full Text] [Related]
34. Causes of death from the randomized CoreValve US Pivotal High-Risk Trial.
Gaudiani V; Deeb GM; Popma JJ; Adams DH; Gleason TG; Conte JV; Zorn GL; Hermiller JB; Chetcuti S; Mumtaz M; Yakubov SJ; Kleiman NS; Huang J; Reardon MJ
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1293-1301.e1. PubMed ID: 28249691
[TBL] [Abstract][Full Text] [Related]
35. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
Elgendy IY; Mahmoud AN; Elbadawi A; Elgendy AY; Omer MA; Megaly M; Mojadidi MK; Jneid H
Catheter Cardiovasc Interv; 2019 Apr; 93(5):989-995. PubMed ID: 30569661
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Outcomes with Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials.
Kundu A; Sardar P; Malhotra R; Qureshi WT; Kakouros N
Cardiovasc Revasc Med; 2020 Apr; 21(4):453-460. PubMed ID: 31669113
[TBL] [Abstract][Full Text] [Related]
37. Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial.
Amrane H; Deeb GM; Popma JJ; Yakubov SJ; Gleason TG; Van Mieghem NM; Reardon MJ;
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):718-728.e3. PubMed ID: 30709668
[TBL] [Abstract][Full Text] [Related]
38. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
[TBL] [Abstract][Full Text] [Related]
39. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis.
Waksman R; Craig PE; Torguson R; Asch FM; Weissman G; Ruiz D; Gordon P; Ehsan A; Parikh P; Bilfinger T; Levitt R; Hahn C; Roberts D; Ingram M; Hanna N; Comas G; Zhang C; Ben-Dor I; Satler LF; Garcia-Garcia HM; Shults C; Rogers T
JACC Cardiovasc Interv; 2020 May; 13(9):1019-1027. PubMed ID: 32381181
[TBL] [Abstract][Full Text] [Related]
40. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
